肺癌是威胁人类健康的主要恶性肿瘤,死亡例数超过乳腺癌、结肠癌和前列腺癌的总和。非小细胞肺癌(NSCLC)占肺癌的80%以上,早期缺乏症状,就诊时疾病已为中晚期,治疗上主要依靠化疗为主的综合治疗。第3代新药含铂方案疗效虽较老的化疗方案有所改善,但缓解率也仅有20%~40%,到疾病 Lung cancer is a major malignancy that threatens human health and the number of deaths exceeds the sum of breast, colon and prostate cancer. Non-small cell lung cancer (NSCLC) accounts for more than 80% of lung cancer, the early lack of symptoms, treatment of disease has advanced, treatment mainly rely on chemotherapy-based comprehensive treatment. The third generation of new drugs containing platinum regimen although the older chemotherapy regimen has improved, but the remission rate was only 20% to 40%, to the disease